Which corticosteroids should be avoided before a tuberculin skin test?

Systemic Corticosteroids Should Be Avoided Before Tuberculin Skin Testing

Systemic corticosteroids at doses equivalent to ≥15 mg/day of prednisone for 1 month or more should be avoided before tuberculin skin testing, as they suppress cell-mediated immunity and can cause false-negative results. 1

Key Steroid Considerations

Systemic Steroids (Must Avoid)

The ATS/CDC guidelines explicitly identify systemic corticosteroids as immunosuppressive agents that interfere with tuberculin skin test (TST) interpretation 1. The critical threshold is:

• Dose: ≥15 mg/day prednisone equivalent
• Duration: ≥1 month of continuous use
• Effect: Patients on these doses are classified in the highest-risk category (>5 mm induration = positive) specifically because steroids suppress the immune response 1

Clinical Evidence Supporting This

Multiple studies confirm systemic steroid interference:

• Recent steroid use dramatically reduces TST positivity: only 3% positive in patients with recent steroid use versus 25% positive in those without steroids in the past 3 months (p=0.002) 2
• Steroid use is significantly associated with TST negativity and anergy 3
• The risk increases with higher doses and longer duration 1

Topical Steroids (Generally Safe)

In contrast, topical corticosteroids do NOT significantly interfere with TST results. Even very potent topical steroids (halcinonide 0.1%) applied directly to the test site only delayed the reaction at 24 hours but did not diminish the induration size at the standard 48-72 hour reading 4. This means:

• Topical/dermatologic steroids are not contraindicated
• The 48-72 hour reading remains accurate even with topical application

Practical Algorithm

Before performing TST:

1. Screen for systemic steroid use

   • Current dose ≥15 mg/day prednisone equivalent?
   • Duration ≥1 month?

2. If YES to both:

   • Consider delaying TST if clinically feasible
   • OR use alternative testing (QuantiFERON-TB Gold, which is less affected by immunosuppression)
   • OR interpret with extreme caution using the >5 mm cutoff for positivity 1

3. If recent steroid use (within 3 months):

   • Expect high false-negative rate
   • Strongly consider IGRA testing instead 2, 3

4. Topical/inhaled steroids:

   • Proceed with TST as planned
   • No special precautions needed 4

Critical Pitfall to Avoid

Do not assume a negative TST rules out latent TB in patients on systemic steroids. The immunosuppression from steroids can mask true infection, leading to missed diagnoses and subsequent reactivation when biologics or additional immunosuppression is added 5. In steroid-treated patients, a negative TST should prompt consideration of alternative testing methods rather than reassurance.